- Lumene unveils product innovation, new packaging for 2014
- Study: 2,000 IUs of vitamin E daily effective in slowing functional decline in AD patients
- Study: Cough-cold manufacturers' voluntary label change on pediatric products reduced ER admissions
- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
- ROUNDTABLE: Pharmacy’s future in sync with technology
NEW YORK — Vitamin C can kill a virulent form of tuberculosis, researchers in New York have found.
The researchers, at Yeshiva University's Albert Einstein College of Medicine, determined that vitamin C was able to kill drug-resistant forms of the bacteria that causes tuberculosis in lab culture, publishing their findings in the online journal Nature Communications. They had been looking into how TB bacteria become resistant to isoniazid, a first-line drug used to treat it.
TB sickened 8.7 million people around the world and resulted in 1.4 million deaths, according to the World Health Organization, and about 650,000 people have multi-drug-resistant forms of the bacteria.